Skip to content

IsraelNational.News

  • Israel
  • Entertain
  • Tech
  • Sports
  • World
  • Business
  • Science
  • Health

IsraelNational.News

  • Israel
  • Entertain
  • Tech
  • Sports
  • World
  • Business
  • Science
  • Health

Biotechnology rule

Biotechnology rule: FDA approval to conduct a trial of a therapeutic vaccine for cancer – the capital market

Biotechnology rule: FDA approval to conduct a trial of a therapeutic vaccine for cancer – the capital market

Dwarf: Success in an experiment designed for bone marrow transplantation – the capital market

Dwarf: Success in an experiment designed for bone marrow transplantation – the capital market

Clal Bio: A subsidiary in negotiations for the development of a vaccine for Corona – the capital market

Clal Bio: A subsidiary in negotiations for the development of a vaccine for Corona – the capital market

Clal Bio: Exit of NIS 88-325 million – Cadnet is sold to Novartis – the capital market

Clal Bio: Exit of NIS 88-325 million – Cadnet is sold to Novartis – the capital market

footer

  • About
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • DMCA
  • Disclaimer
  • Sitemap
  • News-Sitemap
© 2025 IsraelNational.News